NCT07322601

Brief Summary

Introduction: Severe acute pain after cesarean section is an independent risk factor for the development of chronic pain and increases the risk of postpartum depression threefold. Pain also reduces the mother's ability to breastfeed and care for her child. This study aimed to evaluate the supportive effectiveness of auricular acupressure in reducing incision pain and uterine contraction pain in women undergoing cesarean section, compared with sham auricular acupressure. Methods: A randomized, controlled, single-blind clinical trial was conducted in seventy women undergoing cesarean section, randomly allocated (1:1) to an auricular acupressure or sham group. The study group received vaccaria seeds, and the sham group received non-vaccaria patches on both ears. Both groups were treated at the Shenmen, Lung, Internal Genitalia, Pelvis, Subcortex, and Sympathetic points. Pain was assessed using the Visual Analog Scale (VAS), and diclofenac consumption was recorded over the first 48 hours postpartum.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 14, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 14, 2025

Completed
24 days until next milestone

First Posted

Study publicly available on registry

January 7, 2026

Completed
Last Updated

January 7, 2026

Status Verified

October 1, 2025

Enrollment Period

9 months

First QC Date

December 14, 2025

Last Update Submit

December 29, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pain relief effectiveness was assessed using the Visual Analog Scale (VAS) for pain intensity at rest, during movement and for uterine contractions at 12, 24, and 48 hours after cesarean section.

    Pain relief effectiveness was assessed using the Visual Analog Scale (VAS) for pain intensity at rest, during movement and for uterine contractions at 12, 24, and 48 hours after cesarean section. The Visual Analog Scale (VAS) consists of a line where respondents are asked to mark their level of pain. The left-most point (zero) represents no pain and the right-most point (10) represents extreme pain. The higher the score, the more severe the pain.

    12, 24, 48 hours postoperative

  • VAS scores for pain intensity at rest, pain intensity on movement, and uterine contraction pain

    Pain relief effectiveness was assessed using the Visual Analog Scale (VAS) for pain intensity at rest, during movement and for uterine contractions at 12, 24, and 48 hours after cesarean section. The Visual Analog Scale (VAS) consists of a line where respondents are asked to mark their level of pain. The left-most point (0) represents 'no pain,' while the right-most point (10) represents 'extreme pain.' The higher the score, the more severe the pain.

    From enrollment to the end of treatment at 48 hours

Study Arms (2)

Auricular Acupressure Group

EXPERIMENTAL

Participants received auricular acupressure using Vaccaria seeds applied to Shenmen \[Antitragus-4 (TF4)\], Lung \[Concha-14 (CO14)\], Internal Genitalia \[Triangular fossa-2 (TF2)\], Pelvis \[Triangular fossa-5 (TF5)\], Subcortex \[Antitragus-4 (AT4)\], and Sympathetic \[Antihelix-6 (AH6)\].

Other: Auricular Acupressure

Sham Auricular Acupressure Group

SHAM COMPARATOR

Participants received identical adhesive patches without seeds applied to the same auricular points.

Other: Sham Auricular Acupressure Group

Interventions

In the Auricular Acupressure group, participants received auricular acupressure using vaccaria seeds applied to the following points on both ears: Ear Shenmen (TF4), Lung (CO14), Internal Genitalia (TF2), Pelvis (TF5), Subcortex (AT4), and Sympathetic (AH6), in addition to standard postoperative care. Each participant received a single treatment session within 5 hours after cesarean section, once transferred to the Obstetrics Department. Seeds were retained for 2 days. All acupuncture procedures were performed by licensed traditional medicine physicians who had been trained and standardized before the study.

Also known as: Auricular Acupuncture, Acupuncture
Auricular Acupressure Group

In the Sham Auricular Acupressure Group, participants received adhesive patches without seeds, identical in size and appearance to the Auricular Acupressure Group patches, applied to the same auricular points. Both groups received standard postoperative care.

Also known as: Sham Acupuncture, Sham Auricular Acupuncture
Sham Auricular Acupressure Group

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • years of age
  • Gestational age ≥ 37 weeks
  • Alert and cooperative with the treating physicians
  • Able to understand and use the Visual Analog Scale (VAS)
  • Preoperative American Society of Anesthesiologists (ASA) Physical Status Classification System I-II
  • Anesthesia: spinal anesthesia;
  • Pfannenstiel suprapubic transverse incision
  • Infant 5-minute Appearance, Pulse, Grimace, Activity, Respiration score (Apgar score) \> 7
  • Cesarean operative time ≤ 60 minutes
  • Singleton pregnancy
  • Voluntary agreement to participate.

You may not qualify if:

  • Contraindication to diclofenac
  • Surgical complications, including hysterectomy and postpartum hemorrhage (\> 1000 ml)
  • History of acupuncture syncope
  • Preoperative chronic pain and/or regular preoperative use of analgesics
  • Addiction to or dependence on opioids or alcohol
  • Diabetes mellitus or HIV infection
  • Prior Auricular acupressure
  • Skin lesions of the auricle
  • Surgical wound infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Le Van Thinh Hospital

Ho Chi Minh City, Binh Trung Ward, Vietnam

Location

MeSH Terms

Conditions

Pain, PostoperativePain

Interventions

Acupuncture, EarAcupuncture Therapy

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsAuriculotherapy

Study Officials

  • Ly, PhD

    University of Medicine and Pharmacy at Ho Chi Minh City

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants were randomly assigned to the auricular acupressure group or sham auricular acupressure group in a 1:1 ratio.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

December 14, 2025

First Posted

January 7, 2026

Study Start

October 14, 2024

Primary Completion

June 30, 2025

Study Completion

June 30, 2025

Last Updated

January 7, 2026

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will share

The type of data set or supporting information being shared. Options include: study protocol, statistical analysis plan, informed consent form, clinical study report, analytic code.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Beginning 3 months and ending 3 years after the publication of results
Access Criteria
Data will be made available to qualified researchers for the purpose of valid scientific research. To gain access, investigators must submit a formal research proposal and a statistically sound analysis plan to the Principal Investigator. All requests will be reviewed by the study's investigators and the Institutional Ethics Committee. Upon approval, requestors will be required to sign a Data Use Agreement (DUA) to ensure participant confidentiality. The shared data will be de-identified and may include the study protocol and statistical analysis plan.

Locations